„First Line“
Suchergebnisse
3.416 Treffer
-
Overall survival is comparable between percutaneous radiofrequency ablation and liver resection as first-line therapies for solitary 3–5 cm hepatocellular carcinoma
-
Stabilizers and orbits of first level vectors in modules for the special linear groups
-
Quantitative evaluation of the efficacy and safety of first-line systemic therapies for advanced hepatocellular carcinoma
-
Higher Risk of Proteinuria with Atezolizumab plus Bevacizumab than Lenvatinib in First-Line Systemic Treatment for Hepatocellular Carcinoma
-
Real-World Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in Asia-Pacific Countries
-
Phase 2 study of serplulimab with the bevacizumab biosimilar HLX04 in the first-line treatment of advanced hepatocellular carcinoma
-
First-line immune-based combinations or sunitinib in favorable-risk metastatic renal cell carcinoma: a real-world retrospective comparison from the ARON-1 study
-
Efficacy and safety of first-line nivolumab plus ipilimumab treatment in elderly patients (aged ≥ 75 years) with non-small cell lung cancer
-
FAN score predicts prognosis after platinum-based first-line chemotherapy in patients with metastatic urothelial carcinoma
-
Real-world data of dacomitinib as first-line treatment for patients with EGFR-mutant non-small-cell lung cancer
-
Liposomal Irinotecan: A Review as First-Line Therapy in Metastatic Pancreatic Adenocarcinoma
-
Long term efficacy of first-line afatinib and the clinical utility of ctDNA monitoring in patients with suspected or confirmed EGFR mutant non-small cell lung cancer who were unsuitable for chemotherapy
-
Determinants of first-line clinical trial enrollment among Black and White gynecologic cancer patients
-
On-line determination of the chemical composition of single activated cloud condensation nuclei – a first investigation of single urban CCN and CCN obtained from sea water samples
-
Phase II trial of nab-paclitaxel plus ramucirumab in combination with nivolumab for unresectable advanced or recurrent gastric cancer after progression on first-line treatment including fluoropyrimidine, platinum, and anti-PD-1/PD-L1 antibody (PADDLE)
-
Clinical effectiveness and safety of tislelizumab plus TKI as first-line therapy in patients with metastatic renal cell carcinoma (mRCC): a single-center retrospective study
-
An Indirect Treatment Comparison of Lenvatinib for the First-Line Treatment of Patients with Unresectable Hepatocellular Carcinoma
-
Ketamine Versus Midazolam as the First-Line Continuous Infusion for Status Epilepticus in Children with Cardiac Disease
-
Establishment and characterization of the first immortalized vocal cord leukoplakia epithelial cell line
-
First-degree prime ideals of composite extensions